involved in their recruitment to the developing lesions. 8, 9 Directly addressing the role of NK cells in immunity and atherosclerosis has been challenging because of the lack of a good animal model of NK-cell deficiency. Earlier studies used the beige mutant mice, an accepted model of defective NK-cell functional activity, 10 with opposing results. In the first study, beige mutant mice fed a high-fat diet (HFD) containing cholate showed no differences in atherosclerotic lesions compared with controls. 11 However, in a more recent study by Schiller et al, 12 NK cells were ascribed an atheroprotective role when beige mutant mice were bred to Ldlr −/− (low-density lipoprotein receptor null) mice. Beige mutation, which involves the Lyst (lysosomal trafficking regulator) gene encoding a protein implicated in lysosomal trafficking, results in a complicated phenotype that goes beyond decreased NK-cell activity. 13, 14 Defects in cell function may include, in addition to NK cells, neutrophils, macrophages, or smooth muscle cells, 15 making it unclear whether the increase in atherosclerosis in Lyst beige xLdlr −/− mice was a consequence of defective NK-cell function.
Subsequently, different results were observed using an Ly49A transgenic mouse model of NK-cell deficiency. 7 In these transgenic mice, the Ly49A cDNA was expressed under control of the mouse granzyme A genomic sequence, inducing the expression of the receptor on all NK cells and one half of T cells. 16 Ly49A is an inhibitory receptor, which recognizes MHC (major histocompatibility complex) class I molecules. 17 In this transgenic model, the number of NK (NK1.1 + CD3 − ) cells was markedly reduced in the spleen and other peripheral tissues, and the number of NK1.1 + T cells was slightly reduced in the spleen. 16 However, this phenotype, which is not totally understood, is linked to the expression of the ubiquitous transcription factor ATF2 (activating transcription factor 2), raising the possibility of additional defects. 18 Smaller size lesions were observed in Ldlr −/− recipients reconstituted with the BM of ly49A transgenic mice. 7 Although the authors concluded that NK-cell deficiency was responsible for the observed effect, they did not exclude the possibility that T cells, specifically NKT and CD8 subsets, which are known to express granzyme A and whose functions are influenced by Ly49A, 19, 20 could contribute to this proatherogenicity. It is worth mentioning that NKT and CD8 T cells have been classified as proatherogenic cells. 21, 22 Lately, Selathurai et al 23 performed loss-and gain-offunction studies to assess NK-cell function in atherosclerosis. In the loss-of-function experiments, treatment of Apoe −/− mice with anti-asialo-GM1 antibody significantly reduced atherosclerotic lesion development. mice confirmed that its cytotoxic effects are proatherogenic and promote necrotic core development. 23 However, the glycolipid asialoganglioside M1 (GM1) is also expressed by several cell types, including myeloid cells, epithelial cells, and T-cell subsets. Hence, the selectivity of NK-cell depletion with anti-asialo-GM1 antiserum has been questioned. 24 Here, we used 2 state-of-the-art genetic approaches: (1) Rlsl−DTA mice were obtained from Jackson. This line was backcrossed to C57BL/6 for 10 generations by the donating laboratory. 27 In this model, the Cre-mediated removal of the floxed STOP codon leads to the expression of the diphtheria toxin fragment A and consequent cell death. A near to complete absence of NK cells in the BM and every tested organ (including the blood, thymus, lymph nodes, spleen, liver) was observed in these mice. 25 Of note, a deficiency in ILC1 (immune lymphoid cell 1; which also express NKp46) in the liver and in NKp46 + ILC3 in the small intestine was also observed in these mice. Aside from NKp46 + cell deficiency, the immune status of the mice is strictly normal at steady state, in terms of cell populations and activation status. 25 The Noé mice were generated by random mutagenesis, in which a point mutation in the Ncr1 gene impairs the cell surface expression of NKp46 receptor inducing higher capacity to produce IFN-γ and to degranulate. Once generated, Noé mice were backcrossed to C57BL/6J. 26 Ten-week-old male C57BL/6J Ldlr −/− mice were subjected to medullar aplasia by lethal total body irradiation (9. 
Quantification of Atherosclerotic Lesions
Mice were anesthetized with isoflurane before euthanize. Plasma cholesterol was measured using a commercial kit (DiaSys Cholesterol FS*, Germany). Quantification of lesion size and composition was performed as previously described. 29 In brief, the heart and ascending aorta were removed, perfusion-fixed in situ with 4% paraformaldehyde, then placed in PBS 30% sucrose solution overnight, before being embedded in frozen optimal cutting temperature compound, and frozen at −70°C. Afterward, 10-μm serial sections of aortic sinus were obtained (cut on cryostat). Lipids were detected using oil red O (Sigma-Aldrich, St. Louis, MO) coloration and quantified by a blinded operator using HistoLab software (Microvisions Instruments, Paris, France), 30 which was also used for morphometric studies. En face quantification was used for atherosclerotic plaques along thoracoabdominal aorta, as previously described. 29 Collagen was detected using Sirius red staining. The presence of macrophages was determined using monoclonal rat anti-mouse macrophage/monocyte antibody (specifically MAB1852).
At least 4 sections per mouse were examined for each immunostaining, and appropriate negative controls were used.
For NK-cell tracking, frozen sections of spleen and aortic sinus of Ncr-1 gfp/gfp → Ldlr −/− mice were stained with rabbit anti-GFP (green fluorescent protein) antibody (NK cells) and counterstained with DAPI (nuclear dye) and monocytes/macrophages antibody.
To detect NK cells in human plaques, immunostaining studies were performed in atherosclerotic plaques from carotid arteries obtained after surgical thromboendarterectomy (Pathology Department, HEGP Hospital, Paris). We used a specific antibody against human NKp46 (generous gift of Innate Pharma, Marseille, France) in formalin-fixed paraffin-embedded tissues after antigen retrieval by heating in citrate buffer and ABC (avidin-biotin-peroxidase complex) peroxidase technique as previously described. 31 Spleen was used as an internal control in the 2 separate experiments.
Spleen Cell Culture and Cytokine Assays
Cells were cultured in RPMI 1640 medium supplemented with Glutamax (Thermo Fischer Scientific), 10% fetal calf serum, 0.02 mmol/L β-mercaptoethanol, and antibiotics. For cytokine measurements, splenocytes were cultured at 5×10 5 cells per well for 24 hours and stimulated with lipopolysaccharide (1 μg/mL) and IFN-γ (100 UI/mL; Sigma). IL-6 (interleukin 6), IL-12, TNF-α (tumor necrosis factor α), IL-1β, IL-10, and IFN-γ productions in the supernatants were measured using specific ELISA (R&D Systems). 
Flow Cytometry
2) from eBiosciences, Alexa fluor 700-conjugated anti-CD8 (53-6.7), Brilliant Violet 421-conjugated anti-IFN-γ (XMG1.2) and fluorescein isothiocyanate-conjugated anti-CD107a (1D4B) from Biolegend, fluorescein isothiocyanate-conjugated anti-Ly6C (AL-21), PE-conjugated anti-Ly6G (1A8), PerCp-Cy5.5-conjugated Gr-1 (RB6-8C5), PE-Cy7-conjugated anti-CD11c (HL3), and APCconjugated anti-IgM (11/41) from BD Biosciences. For blood staining, erythrocytes were lysed using BD fluorescence-activated cell sorter lysing solution (BD Biosciences). For intracellular cytokine staining, lymphocytes were stimulated in vitro with leukocyte activation cocktail (BD Biosciences) according to the manufacturer's instructions for 4 hours. Surface staining was performed before permeabilization using Foxp3 staining buffer kit (eBiosciences) and intracellular staining.
Forward scatter and side scatter were used to gate live cells excluding red blood cells, debris, and cell aggregates in total blood cells, splenocytes, and BM. Single-cell suspensions stained with fluorophore-conjugated antibodies were acquired using an LSRII Fortessa (BD) flow cytometer and analyzed with FlowJo software (Miltenyi). January 5, 2018
NK-Cell Stimulation
For specific NK-cell stimulation, spleen cell suspensions were dispensed into 96-well 2HB Immulon plate previously coated with 25 μg/mL of purified anti-NK1.1 antibody or 10 μg/mL of antiNKp46 antibody. Anti-CD107a antibody was added in the presence of monensin for 4 hours.
For IL-12/18 stimulation, spleen cells were incubated with 25 ng/mL IL-12 and 20 ng/mL IL-18 (R&D systems) for 4 hours in the presence of monensin. Cells were surface stained and intracellular IFN-γ was revealed.
LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Thermo Fischer Scientific, L34957) was used as a viability dye, and the percentage of IFN-γ-producing and CD107a-expressing NK cells was detected by Flow cytometry as mentioned above.
Quantitative Real-Time Polymerase Chain Reaction
Total RNA from spleen or abdominal aorta was extracted using Trizol reagent (Invitrogen). Quantitative real-time polymerase chain reaction was performed on an ABI Prism 7700 Sequence Detection System (Thermo Fisher Scientific, Inc) in duplicates. Cycle threshold for GAPDH was used to normalize gene expression of samples. Relative expression was calculated using the 2-δ computed tomography method followed by geometric average, as recommended. 32, 33 The following primer sequences were used: IL-10 (F: 5′ AAG TGA TGC CCC AGG CA 3′; R: 5′ TCT CAC CCA GGG AAT TCA AA 3′), perforin (F: 5′ ACA GTA GAG TGT CGC ATG TAC AGT TT 3′; R: 5′ GAG GGC TCT GAG CGC CTT TTT GAA 3′), granzyme B (F: 5′ ACT CTT GAC GCT GGG ACC TA; R: 5′ AGT GGG GCT TGA CTT CAT GT 3′), IFN-γ (F: 5′ TCA AGT GGC ATA GAT GTG GAA AGA A 3′; R: 5′ TGG CTC TGC AGG ATT TTC ATG 3′), TGF-β (F: 5′ CGG CCG GAA ATT CCC AGC TTC T 3′; R: 5′ GTG AGA CGG GCT TCG GGG TCA T 3′), TNF-α (F: 5′ GAT GGG GGG CTT CCA GAA CT 3′; R: 5′ CGT GGG CTA CAG GCT TGT CAC 3′), IL-1β (F: 5′ GAA GAG CCC ATC CTC TGT GA 3′; R: 5′ GGG TGT GCC GTC TTT CAT TA 3′), and IL-6 (F: 5′ AAA GAC AAA GCC AGA GTC CTT CAG AGA GAT 3′; R: 5′ GGT CTT GGT CCT TAG CCA CTC CTT CTG T 3′). Polymerase chain reaction conditions were 10 minutes at 95°C; 42 cycles of 95°C for 15 s, 60°C for 30 s, and a final extension of 72°C for 30 s.
Statistical Analysis
Values are expressed as mean±SEM. Differences between values were evaluated using nonparametric Mann-Whitney test or 1-way ANOVA with Bonferroni correction to compare >2 groups. All these analyses were performed using GraphPad Prism version 5.0b for Mac (GraphPad Software), and values were considered significant at P <0.05.
Results

Genetic NK-Cell Depletion Does Not Alter the Development of Atherosclerosis
To assess the direct role of NK cells in the development of atherosclerosis, we performed BM transplantation experiments using either control (WT) or Ncr1 Table) . Interestingly, NK-cell deficiency did not alter lesion size in aortic root and thoracic aorta after 8-week (Figure 2A and 2B), 12-week ( Figure 2C and 2D) , or 15-week ( Figure 2E and 2F) HFD. Similarly, no effect was observed on atherosclerosis development in female Ldlr −/− mice reconstituted with BM of control or Ncr1 iCre
R26
lsl−DTA mice and put on HFD for 8 weeks (Online Figure IIA through IIC) . To determine whether plaque composition was affected by NK-cell depletion, we analyzed macrophage content (Online Figure IID and IIE) , collagen content (Online Figure IIF and IIG) , and necrotic core (data not shown), but found no significant differences between groups.
Furthermore, we investigated the immune-inflammatory response in chimeric Ldlr −/− mice because NK cells are known to produce cytokines in response to infection or inflammation. 34 The expression levels of IL-6, IL-10, IL-1β, IL-12p70, TNF-α, and TGF-β mRNA measured in the spleen were not different between control and NK-cell-deficient chimeric mice (Online Figure IIIA) . Lipopolysaccharide and IFN-γ-stimulated splenocytes from chimeric control or Ncr1
lsl−DTA mice also showed no difference in inflammatory phenotype with same levels of IL-6, IL-10, and TNF-α (Online Figure IIIB) .
Hyperresponsive NK Cells Do Not Promote Atherosclerosis Development
We next addressed the role of NK-cell hyperresponsiveness in atherosclerosis by using Noé mice, in which a point mutation in the Ncr1 gene impairs the cell surface expression of the NKp46 receptor inducing a higher capacity to produce IFN-γ and to degranulate. 26 We performed BM transplantation experiments using Noé or control (C57/B6J) mice to reconstitute the BM of male Ldlr −/− mice. After 8-week HFD, an intact NK-cell population (CD3 − NK1.1 + ) was detected in Noé chimeric mice compared with controls ( Figure 3A through 3C). The frequencies of other leukocyte populations were also the same in spleen and blood of mice reconstituted with the WT or Noé BM (Online Figure IVE and IVF) . Interestingly, a higher frequency of IFN-γ-producing NK cells was observed in chimera mice reconstituted with the Noé BM. However, no difference in plaque size, aortic root, and thoracic aorta ( Figure 3D through 3G) or plaque composition in terms of macrophage accumulation or collagen content (Online Figure  IVA through IVD) was observed between groups. No difference in immune-inflammatory response was detected either (data not shown). This series of experiments was repeated twice, and similar results were found. There were no differences in plasma cholesterol levels or mice body weight between Noé and control chimeric mice (Online Table) .
These data show that NK-cell hyperresponsiveness observed in Noé mice is not sufficient to affect the development of atherosclerosis.
Anti-Asialo-GM1-Mediated Decrease in Atherosclerosis Is NK Cell Independent
The findings with the above 2 experiments were unexpected, given that the latest study on the role of NK cell in atherosclerosis came up with the conclusion that NK cells are proatherogenic through their production of perforin and granzymes. 23 Hence, we revisited the experimental model of Selathurai et al, 23 in which the authors used anti-asialo-GM1 antibody to deplete NK cells in Apoe −/− mice. We treated control (WT→ Ldlr Initially, we examined the effectiveness of antiasialo-GM1 treatment for depleting NK cells in peripheral blood. A single dose of anti-asialo-GM1 antibody was sufficient to deplete NK cells within 5 days by >80% in WT chimeric mice (Table) lsl−DTA chimeric mice compared with control groups treated with control serum (Table) .
Similar effects in blood and spleen cells were observed in anti-asialo-GM1-treated chimeric mice after 8-week HFD. Anti-asialo-GM1 treatment led to almost 80% reduction of NK cells in control mice, between 60% and 80% reduction in NKT cells in control and NK-cell-deficient chimeric mice, respectively, and 30% reduction in CD8 T cells in both groups (Table) .
Although anti-asialo-GM1 treatment seemed to be less effective in depleting NKT and CD8 + T-cell populations after 8-week HFD in the spleen, the trend toward a smaller size population persisted (Online Figure VA) . There were no differences in the percentage of monocytes, but we observed a trend of decrease in blood (Table) and spleen (data not shown) neutrophils.
Importantly, IFN-γ-producing CD8 + T-cell population was significantly decreased by almost 50% in anti-asialo-GM1-treated Ncr1 iCre
R26
lsl−DTA chimeric mice with a trend also in control anti-asialo-GM1-treated chimeric mice (P=0.077), whereas no significant differences were observed in IFN-γ-producing CD4 + T cells (Online Figure VB) . Lesion size decreased significantly by 42% in anti-asialo-GM1-treated control chimeric mice compared with mice treated with control serum (Figure 4) . However, more interestingly, similar effects were observed in NKcell-deficient chimeric mice with 68% reduction in aortic root lesion size in anti-asialo-GM1-treated Ncr1 iCre R26 lsl−DTA chimeric mice compared with mice treated with control serum (Figure 4) , despite similar plasma cholesterol levels (Online Table) . Therefore, we concluded that reduction of atherosclerotic lesions by anti-asialo-GM1 treatment was NK cell independent.
NK Cells Exacerbate Atherosclerosis Development in Inflammatory Conditions
Finally, we addressed the role of NK cells in the development of atherosclerosis in inflammatory conditions in which these cells are known to be activated. To do so, we used poly(I:C), which mimics a viral infection. Control (WT→ Ldlr
) chimeric mice were treated repeatedly with 100 μg poly(I:C) twice a week, whereas another control group (WT→ Ldlr −/− mice) was treated in parallel with saline over 8-week HFD.
Interestingly, after 8-week HFD, poly(I:C) treatment of control mice significantly increased CD69 and CD107a expression on NK cells compared with control mice that received saline, although the increase in frequency of IFN-γ-producing NK cells was not significant. As expected, the percentage of NK cells significantly decreased by almost 50% in the spleen of poly(I:C)-treated compared with saline-treated chimeric mice reconstituted with WT BM (Figure 5A) . Moreover, the expression of perforin, granzyme B, and IFN-γ mRNA was significantly enhanced in the spleen after poly(I:C) treatment, which also holds true for granzyme B in the aorta ( Figure 5B) . Interestingly, the expression of granzyme B mRNA, but not IFN-γ, in the spleen and aorta was reduced in poly(I:C)-treated NK-deficient mice. This further confirms NK-cell activation in response to poly(I:C) treatment.
Although no change in aortic root plaque size was observed in poly(I:C)-treated compared with saline-treated (WT→ Ldlr Figure VIA) . No change in collagen content was detected (Online Figure VIB) . No differences in body weight or serum cholesterol levels were observed between the 3 groups of mice (Online Table) . Hence, NK cells might be proatherogenic when activated in a systemic inflammatory context.
NK Cells Are Scarcely Detected in Human and Mouse Atherosclerotic Lesions
To specifically track NK-cell homing to atherosclerotic lesions in hypercholesterolemic mice, we reconstituted lethally irradiated Ldlr −/− mice with BM from Ncr-1 gfp/gfp mice. After 8-week HFD, staining of atherosclerotic lesions with anti-GFP antibody showed very low number of NK cells, 1 to 2 cells per lesion examined ( Figure 7A ). In contrast, NK cells were abundant in the spleen. In human, we also found very few NK cells in atherosclerotic plaques. Only 1 or 2 cells were detected in the plaques of uncomplicated atherosclerosis, whereas none were observed in advanced plaque lesions ( Figure 7B) . Specificity of the anti-human NKp46 antibody was tested in human spleen samples. 
Discussion
Using 2 state-of-the-art genetic approaches, our study provides strong evidence that, in contrast to most previous studies, NK cells have no role in atherosclerosis development, unless a systemic inflammation is induced. Transfer of the BM of selectively depleted (Ncr1
) or hyperresponsive (Noé) mice into lethally irradiated Ldlr −/− mice had no effect on plaque size (aortic root and thoracic aorta) and composition, or immune-inflammatory response, when compared with control mice. However, treating NK-cell-deficient chimeric mice with poly(I:C), in an attempt to mimic viral infection, significantly reduced lesion size, which suggests that NK cells might be proatherogenic only when activated by virus infection or inflammatory cytokines or in the context of tumor growth.
Earlier studies on the role of this innate immune cell population in atherosclerosis led to conflicting results. The very first studies to examine the role of NK cells in atherosclerosis used the beige mutant mice. Accelerated atherosclerosis was observed in beige Ldlr −/− mice, and NK cells were accredited to be antiatherogenic. 12 However, an alternative NK-cell-independent hypothesis is most likely because the beige mutation which leads to functional changes in lysosome trafficking may involve other cells such as lesion macrophages or smooth muscle cells leading to increased foam cell formation or apoptosis. 10, 35 In contrast to these studies, Ldlr −/− mice repopulated with Ly49A transgenic mice BM and which present an NK-cell deficiency exhibited reduced atherosclerosis. 7 However, the expression of the inhibitory receptor Ly49A, which is regulated by granzyme A promoter in this model, is induced not only in NK cells but also in subsets of CD4 + and CD8 + T cells. 16 Hence, this expression on T cells could be responsible for the decrease in lesion size in Ly49A transgenic BM recipients. Lately, experiments in Apoe −/− mice fed an HFD treated with anti-asialo-GM1 antibody to deplete NK cells attenuated atherosclerosis. In addition, adoptive transfer of ex vivo activated NK cells increased lesion size in lymphocyte-deficient Apoe −/− mice, an effect that was prevented by transferring perforin-or granzyme-deficient NK cells, which suggests that NK cells augment atherosclerosis via cytotoxic dependent mechanisms. 23 However, the expression of asialo-GM1 is not strictly confined to NK cells among hematopoietic cells and is detected in subpopulations of NKT, CD8 T, and γδ T cells 36, 37 and in some activated forms of CD4 + T cells, macrophages, eosinophils, and basophils under certain experimental conditions. [38] [39] [40] Our data suggest that the discrepancy observed in former studies was most likely because of effects on other cell populations targeted in addition to NK cells. Indeed, our study clearly demonstrates that NK cells have no role in atherosclerosis development.
NKp46 is also expressed in ILC1 and a subset of ILC3 (NKp46 + ILC3s). These cells are also deleted in the Ncr1 iCre
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DTA mice. 25 In our experimental protocol, recipient mice were irradiated before BM transplantation. Both NK cells and ILC1s are sensitive to irradiation and should thus originate from donor BM. About the ILC3 population, NKp46
− ILC3 have been shown to be resistant to irradiation, 41 
DTA BM into irradiated Ldlr −/− mice, not only NK cells but also ILC1s and potentially NKp46+ ILC3s should have been depleted, whereas other lymphocytes and myeloid cells were unaffected, suggesting that these other ILCs subset do not play a major role in atherosclerosis either.
Moreover, we questioned the specificity of using antiasialo-GM1 treatment to target NK cells in the context of atherosclerosis. We clearly demonstrated that its effect was NK cell independent as atherosclerosis was reduced by anti-asialo-GM1 treatment to the same extent in control and NK-deficient mice. We observed that the anti-asialo-GM1 treatment not only depleted NK cells but also strongly reduced NKT and CD8 + T-cell population after 8-week HFD. Among CD8 + T cells, the IFN-γ-producing CD8 T cells were also reduced. This is consistent with a previous study showing that the asialo-GM1 + CD8 population is high in IFN-γ-producing cells in response to stimulus. 36 These activated CD8 + T cells which are targeted by anti-asialo-GM1 antibodies might thus be involved in the phenotype observed in atherosclerosis. This is consistent with the fact that CD8 + T-cell activation has been shown to exacerbate atherosclerosis. 43 About the NKT cell population, although previous studies indicate that NK-cell depletion with antibody against asialo-GM1 does not always drastically affect the size or function of NKT cell population, 44 NKT cell population was significantly decreased in hypercholesterolemic mice treated with anti-asialo-GM1 antibody. NKT cells are considered proatherogenic. 45 Their depletion could thus also contribute to the protective phenotype in antiasialo-GM1-treated mice.
We used 2 models in which NK cells functions are increased: the Noé model in which NK cells are known to be intrinsically hyperresponsive and the poly(I:C) model in which NK cells are activated because of an inflammatory environment. 
